Entrada Therapeutics, Inc.
TRDA
$7.46
$0.010.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.50% | -13.81% | -9.53% | -7.68% | -7.45% |
| Total Receivables | -24.97% | -11.25% | -19.37% | -5.44% | -25.62% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -17.92% | 32.89% | -10.99% | -30.04% | -27.15% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -12.80% | -12.86% | -9.46% | -8.37% | -8.44% |
|
|
|||||
| Total Current Assets | -12.80% | -12.86% | -9.46% | -8.37% | -8.44% |
| Net Property, Plant & Equipment | -3.83% | -3.69% | -3.92% | -6.57% | -4.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.83% | 0.59% | -18.26% | -0.87% | -0.95% |
| Total Assets | -10.92% | -11.09% | -8.60% | -8.00% | -7.75% |
|
|
|||||
| Total Accounts Payable | 27.85% | 28.00% | -27.70% | 70.49% | -15.13% |
| Total Accrued Expenses | 12.06% | -33.34% | 11.46% | 30.82% | 69.01% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.92% | 3.46% | -4.87% | -20.36% | -16.10% |
| Total Finance Division Other Current Liabilities | -13.78% | -35.36% | -10.40% | 45.61% | -61.70% |
| Total Other Current Liabilities | -13.78% | -35.36% | -10.40% | 45.61% | -61.70% |
| Total Current Liabilities | 11.34% | -21.50% | 1.80% | 21.29% | 7.44% |
|
|
|||||
| Total Current Liabilities | 11.34% | -21.50% | 1.80% | 21.29% | 7.44% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.02% | -2.83% | -2.61% | -2.50% | -2.39% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -41.75% | -35.55% |
| Total Liabilities | 1.24% | -9.24% | -1.30% | 4.19% | 0.09% |
|
|
|||||
| Common Stock & APIC | 0.94% | 0.84% | 0.79% | 0.90% | 0.96% |
| Retained Earnings | -13.67% | -14.54% | -16.74% | -23.25% | -29.38% |
| Treasury Stock & Other | -73.17% | -62.27% | 4.99% | 55.25% | -8.47% |
| Total Common Equity | -13.82% | -11.52% | -10.15% | -10.22% | -9.05% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.82% | -11.52% | -10.15% | -10.22% | -9.05% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.82% | -11.52% | -10.15% | -10.22% | -9.05% |
|
|
|||||